Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

Liposomes improve drug delivery and reduce skin irritation in dermatology.

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.

New treatments targeting specific genes show promise for treating keratin disorders.

A mutation in the KRT75 gene causes frizzle feathers in chickens.

Hair elemental analysis could be useful for health and exposure assessment but requires more standardization and research.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

Made 8 minoxidil samples; 1 cocrystal, 7 salts formed.

Noggin overexpression delays eyelid opening by affecting cell death and skin cell development.

Acne keloidalis nuchae is a tough-to-treat condition that greatly affects quality of life, especially in men of African descent.

Certain proteins, caspases-1 and -11, are important in the early development of skin inflammation in mice.

The article explains the genetic causes and symptoms of various hair disorders and highlights the need for more research to find treatments.

Genetically modified plants could be an important source of omega-3 fats to meet global needs.

Genetic mutations can cause hair growth disorders by affecting key genes and signaling pathways.

The study concludes that the EDA2R gene is activated by p53 during chemotherapy but is not necessary for chemotherapy-induced hair loss.

Alopecia Areata is a complex, unpredictable autoimmune hair loss condition with limited treatment options and a significant psychological impact.

Mutations in the WNT10A gene can cause skin, hair, teeth, and other disorders, and may also affect other areas like kidney and cancer, with potential for targeted treatments.

Researchers found genetic mutations causing hypohidrotic ectodermal dysplasia in 88% of studied patients and identified new mutations and genetic variations affecting the disease.

Future research on ectodysplasin should explore its role in diseases, stem cells, and evolution, and continue developing treatments for genetic disorders like hypohidrotic ectodermal dysplasia.

New genetic factors linked to acne risk were discovered, highlighting the role of certain pathways and genes.

Certain microRNAs are linked to various skin diseases and could be used to diagnose and treat these conditions.

Mutations in certain receptors can cause diseases and offer new treatment options.

The document concludes that understanding hair follicles requires more research using computational methods and an integrative approach, considering the current limitations in hair treatment products.

Toxic Epidermal Necrolysis is a rare, serious skin condition that can affect anyone, is more common in women, and may be linked to genetics, with a 20% mortality rate mainly due to sepsis.

Women with PCOS have a higher risk of severe COVID-19 due to related health issues.

Platelet-rich plasma (PRP) is a safe and potentially effective way to treat hair loss, especially when combined with minoxidil.

Hormonal imbalances, often indicating conditions like PCOS, are common in women with hard-to-treat acne, and a treatment approach addressing these imbalances may be needed.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

Different sPLA2 enzymes affect immunity, skin and hair health, reproduction, and may be potential targets for therapy.

Genetic discoveries are key for understanding, diagnosing, and treating inherited hair and nail disorders.